Immunodiagnostics Global Market Opportunities And Strategies To 2033
상품코드:1480366
리서치사:The Business Research Company
발행일:2024년 05월
페이지 정보:영문 296 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계 면역진단 시장은 2018년 146억 4,640만 달러로 평가되었으며, 2023년까지 연평균 7.0% 이상 성장할 것으로 예상됩니다.
의료비 지출의 증가
의료비 지출 증가는 실적 기간 동안 면역진단 시장의 성장을 견인했습니다. 의료비 지출은 혁신을 촉진하고 첨단 기술에 대한 접근성을 향상시키는 데 필수적입니다. 의료 예산이 증가함에 따라 질병을 감지하고 모니터링하는 데 매우 중요한 역할을 하는 면역 진단을 포함한 첨단 진단 기술에 대한 수요가 급증했습니다. 이러한 지출 증가는 의료 기관이 최첨단 장비와 혁신적인 진단 솔루션에 투자할 수 있는 여력을 제공함으로써 시장 성장의 원동력이 되고 있습니다. 메디케어 및 메디케이드 등 미국의 주요 의료 프로그램을 관리하는 연방 기관인 메디케어 및 메디케이드 서비스 센터(Medicare & Medicaid Service Center)에 따르면, 2020년 미국의 의료 지출은 9.7% 증가하여 4조 1,000억 달러, 1인당 1만 2,530달러에 달했습니다. 국내총생산(GDP)에서 의료비가 차지하는 비중은 2020년 영국에서 19.7%, 2,690억 파운드(3,544억 5,000만 달러)로 명목상으로는 2019년 지출보다 20% 증가했습니다. 따라서 의료 지출의 증가는 면역 진단 시장의 성장을 촉진했습니다.
목차
제1장 주요 요약
면역진단 - 시장 매력과 거시경제 상황
제2장 목차
제3장 표목차
제4장 그림목차
제5장 보고서 구성
제6장 시장 특징
일반적인 시장 정의
개요
면역진단 시장 정의와 세분화
제품별 시장 세분화
시약과 소모품
기기
소프트웨어와 서비스
시장 세분화 : 기술별
효소면역측정법
화학발광면역측정법
형광면역측정
방사면역측정
신속 시험
기타
시장 세분화 : 용도별
감염증
종양학과 내분비학
뼈와 미네랄 질병
자가면역질환
심장 바이오마커
간염과 레트로바이러스 시험
기타
시장 세분화 : 최종사용자별
병원
클리닉
진단 실험실
학술연구기관
기타
제7장 주요 시장 동향
신속한 결과를 제공하는 POC(Point of Care) 면역진단 채용
DNA 증폭 기술을 이용한 면역측정 민감도 향상
시장 진출 기업 간의 전략적 파트너십
제8장 면역진단 시장 : 거시경제 시나리오
COVID-19의 영향 : 면역진단 시장
우크라이나 전쟁의 영향 : 면역진단 시장
고인플레이션의 영향 : 면역진단 시장
제9장 세계의 시장 규모와 성장
시장 규모
시장 성장 실적, 2018-2023년
시장 성장 촉진요인, 2018-2023년
시장 성장 억제요인, 2018-2023년
시장 성장 예측, 2023-2028년, 2033년
시장 성장 촉진요인, 2023-2028년
시장 성장 억제요인, 2023-2028년
제10장 세계의 면역진단 시장 : 세분화
세계의 면역진단 시장 : 제품별, 실적과 예측, 2018-2023년, 2028년, 2033년
세계의 면역진단 시장 : 용도별, 실적과 예측, 2018-2023년, 2028년, 2033년
세계의 면역진단 시장 : 최종사용자별, 실적과 예측, 2018-2023년, 2028년, 2033년
세계의 면역진단 시장 : 기술별, 실적과 예측, 2018-2023년, 2028년, 2033년
제11장 면역진단 시장 : 지역·국가별 분석
세계의 면역진단 시장 : 지역별, 실적과 예측, 2018-2023년, 2028년, 2033년
세계의 면역진단 시장 : 국가별, 실적과 예측, 2018-2023년, 2028년, 2033년
제12장 아시아태평양 시장
제13장 서유럽 시장
제14장 동유럽 시장
제15장 북미 시장
제16장 남미 시장
제17장 중동 시장
제18장 아프리카 시장
제19장 경쟁 상황과 기업 개요
기업 개요
Abbott Laboratories
F. Hoffman-La Roche Ltd
Thermo Fisher Scientific Inc.
Danaher Corporation
DiaSorin S.p.A.
제20장 경쟁 벤치마킹
제21장 경쟁 대시보드
제22장 주요 인수합병
Novacyt Acquired Yourgene Health
Freenome Acquired Oncimmune Ltd.
DiaSorin S.p.A Acquired Luminex Corporation
Avacta Group plc Acquired Launch Diagnostics Holdings Limited
Heska Acquired LightDeck Diagnostics
제23장 기회와 전략
세계의 면역진단 시장, 2028년 : 새로운 기회를 제공하는 국가
세계의 면역진단 시장, 2028년 : 새로운 기회를 제공하는 부문
세계의 면역진단 시장, 2028년 : 성장 전략
시장 동향 다른 전략
경쟁 전략
제24장 면역진단 시장 : 결론과 제안
결론
제안
제품
장소
가격
프로모션
인재
제25장 부록
ksm
영문 목차
영문목차
Immunodiagnostics refers to a branch of medical diagnostics that utilizes antibodies to detect diseases or conditions. This field relies on the specific interactions between antigens (substances that stimulate an immune response) and antibodies (specific binding proteins produced by immune cells in response to antigens). Immunodiagnostic tests can identify the presence of antigens produced by pathogens such as viruses, bacteria or parasites, as well as detect proteins produced by the body in response to pathogens or pathological changes in organs, tissues and cells in response to disease or injury.
The immunodiagnostics market consists of sales, by entities (organizations, sole traders and partnerships), of immunodiagnostics products and services that utilize the antibodies to detect and measure specific substances through antigen-antibody reactions.
The global immunodiagnostics market was valued at $14,646.4 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 7.0%.
Rise In Healthcare Expenditure
The rise in healthcare expenditure drove the expansion of the immunodiagnostics market during the historic period. Healthcare expenditure is essential for driving innovation and improving access to advanced technologies. As healthcare budgets increased, there was a corresponding surge in demand for advanced diagnostic technologies, including immunodiagnostics, which played a pivotal role in disease detection and monitoring. This increased expenditure allowed healthcare facilities to invest in state-of-the-art equipment and innovative diagnostic solutions, driving market growth. According to the Centers for Medicare & Medicaid Services, a US-based federal agency that administers the nation's major healthcare programs including Medicare and Medicaid, health spending in the USA grew by 9.7% in 2020, reaching $4.1 trillion or $12,530 per person. As a share of the nation's Gross Domestic Product, health spending accounted for 19.7% of GDP in the UK in 2020, which is £269 billion ($354.45 billion), a nominal-terms increase of 20% on spending in 2019. Therefore, the rise in healthcare expenditure propelled the growth of the immunodiagnostics market.
Increasing Immunoassay Sensitivity Using DNA Amplification Technology
Companies operating in immunodiagnostics are increasing immunoassay sensitivity using DNA amplification technology. This approach involves amplifying target DNA sequences associated with specific biomarkers, thereby increasing the detectability of analytes in biological samples. By integrating DNA amplification techniques such as polymerase chain reaction (PCR), into immunoassay platforms, companies can achieve greater sensitivity and accuracy in detecting low-concentration analytes. For instance, in May 2021, Cavidi, a Sweden-based pharmaceutical and diagnostic company, introduced a groundbreaking platform technology called Exazym, signal generating technology to bring ultra-sensitive detection-levels to conventional immunodiagnostic assays. This innovative technology offers a novel signal amplification method known as Binding Oligo Ladder Detection (BOLD), which significantly enhances immunoassay signal amplification by up to 100 times.
The global immunodiagnostics market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 23.25% of the total market in 2022.
Immunodiagnostics Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global immunodiagnostics market as it emerges from the COVID-19 shut down.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for immunodiagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The immunodiagnostics market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider immunodiagnostics market; and compares it with other markets.
The report covers the following chapters
Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by technology, by application and by end-user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the immunodiagnostics market.
Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis - Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by technology, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
Competitive Dashboard - Briefs on competitive dashboard of major players.
Key Mergers And Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for immunodiagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups next five years.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) By Product: Reagents And Consumables; Instruments; Software And Services
2) By Technology: Enzyme-Linked Immunosorbent Assay; Chemiluminescence Immunoassay; Fluorescent Immunoassay; Radioimmunoassay; Rapid Test; Other Technologies
3) By Application: Infectious Diseases; Oncology And Endocrinology; Bone And Mineral Diseases; Autoimmunity Disorders; Cardiac Biomarkers; Hepatitis And Retrovirus Testing; Other Applications
4) By End-User: Hospitals; Clinics; Diagnostic Laboratories; Academic And Research Institutes; Other End-Users
